Table 4 Antimalarial and antibiotics exposure in relation to pregnancy outcome (n = 994)
Variables | Outcomes | Crude OR | Pμ | Adjusted ORα | Pμ | |
|---|---|---|---|---|---|---|
(95% CI) | (95% CI) | |||||
Birth outcome | MC/SB | Live birth | ||||
n (%) | n (%) | |||||
Antimalarial exposure* | 1.2 (0.6 – 2.3) | 0.546 | 1.3 (0.7 – 2.4) | 0.494 | ||
Yes | 12 (17.4) | 136 (14.7) | ||||
No | 57 (82.6) | 789 (85.3) | ||||
Antibiotics exposure | 0.8 (0.4 – 1.6) | 0.551 | 0.8 (0.4 – 1.6) | 0.526 | ||
Yes | 10 (14.5) | 160 (17.3) | ||||
No | 59 (85.5) | 765 (82.7) | ||||
Birth weight (grams) | < 2500 | ≥ 2500 | ||||
n (%) | n (%) | |||||
Antimalarial exposure* | 0.7 (0.3 – 1.9) | 0.523 | 0.7 (0.3 – 1.8) | 0.460 | ||
Yes | 5 (11.4) | 131 (14.9) | ||||
No | 39 (88.6) | 750 (85.1) | ||||
Antibiotics exposure | 0.6 (0.2 – 1.5) | 0.291 | 0.6 (0.2 – 1.6) | 0.295 | ||
Yes | 5 (11.4) | 155 (17.6) | ||||
No | 39 (88.6) | 726 (82.4) | ||||
Maturity status at birth | Preterm | Term | ||||
n (%) | n (%) | |||||
Antimalarial exposure* | 1.1 (0.5 – 2.5) | 0.742 | 1.2 (0.6 – 2.7) | 0.629 | ||
Yes | 8 (16.3) | 128 (14.6) | ||||
No | 41 (83.7) | 748 (85.4) | ||||
Antibiotics exposure | 1.4 (0.7 – 2.8) | 0.329 | 1.4 (0.7 – 2.8) | 0.348 | ||
Yes | 11 (22.5) | 149 (17.0) | ||||
No | 38 (77.5) | 727 (83.0) | ||||